Market Overview - The pharmaceutical commercial sector increased by 1.96% on September 8, with Baiyang Pharmaceutical leading the gains [1] - The Shanghai Composite Index closed at 3826.84, up 0.38%, while the Shenzhen Component Index closed at 12666.84, up 0.61% [1] Stock Performance - Baiyang Pharmaceutical (301015) closed at 29.09, up 7.11% with a trading volume of 154,200 shares and a transaction value of 437 million yuan [1] - Yifeng Pharmacy (603939) closed at 26.18, up 5.27% with a trading volume of 186,100 shares and a transaction value of 478 million yuan [1] - Dazhenglin (603233) closed at 17.70, up 3.09% with a trading volume of 139,100 shares [1] - Other notable stocks include Renmintongtai (600829) up 2.76% and Jiuzhoutong (600998) up 2.23% [1] Capital Flow - The pharmaceutical commercial sector experienced a net outflow of 124 million yuan from institutional investors, while retail investors saw a net inflow of 72.2 million yuan [2] - The sector's overall capital flow indicates a mixed sentiment among different investor types [2] Individual Stock Capital Flow - Baiyang Pharmaceutical had a net inflow of 47.64 million yuan from institutional investors, but a net outflow of 66.21 million yuan from retail investors [3] - Renmintongtai saw a net inflow of 8.94 million yuan from institutional investors, while retail investors had a net outflow of 707.48 million yuan [3] - Other stocks like Yixin Tang (002727) and Ruikang Pharmaceutical (002589) also showed varied capital flows, indicating differing investor sentiments [3]
医药商业板块9月8日涨1.96%，百洋医药领涨，主力资金净流出1.24亿元